Clinical Trials Browser

Phase 2 × MLN 8237 × Thoracic × Clear all

NCT07465757 2026-03-12

ALISCA-Lung2

Phase 2 Not yet recruiting

Small Cell Lung Carcinoma

NCT06095505 2026-02-17

ALISCA-Lung1

Phase 2 Recruiting

Small Cell Lung Carcinoma

NCT02293005 2022-10-04

Phase II Trial of Alisertib (MLN8237) in Salvage Malignant Mesothelioma

Phase 2 Completed

28 enrolled 11 charts

Other solid neoplasmThoracic

Lung Neoplasms, Mesothelioma